Studies continue to put a harsh light on proton pump inhibitors (PPIs), which are medications used...READ MORE
New Jersey Man Claims $75,000 in Gambling Losses Due to Use of Abilify
Baron & Budd is no longer accepting inquiries for this litigation. For an updated list of our current cases, visit our homepage. Updated: June 16, 2017
The anti-depressant drug Abilify has been linked to many types of impulsive behavior, including gambling. A man in New Jersey is suing the maker of the drug, claiming his use of Abilify led to more than $75,000 in gambling losses.
Before and After
The plaintiff in the case claims that he started taking Abilify in 2010 and then began to gamble compulsively soon afterward. When he stopped taking the drug three years later, he claims, he also stopped gambling. He is suing on the grounds that Abilify’s warning label does not mention the potential risk for compulsive gambling. The plaintiff is suing for fraud, negligence and breach of contract, and is seeking actual and punitive damages.
Studies Back Up Claims
While researchers are unclear as to exactly why Abilify use can lead to compulsive gambling and other impulse control issues, they theorize that the medication has an effect on the brain’s mood and behavior receptors. They believe Abilify over-stimulates these receptors, leading to compulsive behavior as a result.
Several studies have shown a potential lead between Abilify and impulse control problems. In 2014, for example, the medical journal Addictive Behaviors published a study conducted by researchers in France analyzing the cases of people undergoing compulsive gambling treatment. They looked at eight patients who were on Abilify and found that seven of them stopped gambling when they ceased taking the drug.
Get Legal Help
Compulsive gambling can lead to not only financial ruin but the destruction of family relationships as well. If you or a loved one experienced this problem after taking Abilify, you may be able to file a lawsuit against the manufacturer. Please complete our contact form or call 866-520-2755 to learn more.